“Drug Survival and Reasons for Discontinuation of the First Course of Biological Therapy in 301 Juvenile Idiopathic Arthritis Patients”. Reumatismo, vol. 65, no. 6, Mar. 2014, pp. 278-85, https://doi.org/10.4081/reumatismo.2013.682.